Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Mucosal metabolites fuel the growth and virulence of E. coli linked to Crohn’s disease
Shiying Zhang, Xochitl Morgan, Belgin Dogan, Francois-Pierre Martin, Suzy Strickler, Akihiko Oka, Jeremy Herzog, Bo Liu, Scot E. Dowd, Curtis Huttenhower, Matthieu Pichaud, Esra I. Dogan, Jack Satsangi, Randy Longman, Rhonda Yantiss, Lukas A. Mueller, Ellen J. Scherl, R. Balfour Sartor, Kenneth W. Simpson
Shiying Zhang, Xochitl Morgan, Belgin Dogan, Francois-Pierre Martin, Suzy Strickler, Akihiko Oka, Jeremy Herzog, Bo Liu, Scot E. Dowd, Curtis Huttenhower, Matthieu Pichaud, Esra I. Dogan, Jack Satsangi, Randy Longman, Rhonda Yantiss, Lukas A. Mueller, Ellen J. Scherl, R. Balfour Sartor, Kenneth W. Simpson
View: Text | PDF
Research Article Inflammation Microbiology

Mucosal metabolites fuel the growth and virulence of E. coli linked to Crohn’s disease

  • Text
  • PDF
Abstract

Elucidating how resident enteric bacteria interact with their hosts to promote health or inflammation is of central importance to diarrheal and inflammatory bowel diseases across species. Here, we integrated the microbial and chemical microenvironment of a patient’s ileal mucosa with their clinical phenotype and genotype to identify factors favoring the growth and virulence of adherent and invasive E. coli (AIEC) linked to Crohn’s disease. We determined that the ileal niche of AIEC was characterized by inflammation, dysbiosis, coculture of Enterococcus, and oxidative stress. We discovered that mucosal metabolites supported general growth of ileal E. coli, with a selective effect of ethanolamine on AIEC that was augmented by cometabolism of ileitis-associated amino acids and glutathione and by symbiosis-associated fucose. This metabolic plasticity was facilitated by the eut and pdu microcompartments, amino acid metabolism, γ-glutamyl-cycle, and pleiotropic stress responses. We linked metabolism to virulence and found that ethanolamine and glutamine enhanced AIEC motility, infectivity, and proinflammatory responses in vitro. We connected use of ethanolamine to intestinal inflammation and L-fuculose phosphate aldolase (fucA) to symbiosis in AIEC monoassociated IL10–/– mice. Collectively, we established that AIEC were pathoadapted to utilize mucosal metabolites associated with health and inflammation for growth and virulence, enabling the transition from symbiont to pathogen in a susceptible host.

Authors

Shiying Zhang, Xochitl Morgan, Belgin Dogan, Francois-Pierre Martin, Suzy Strickler, Akihiko Oka, Jeremy Herzog, Bo Liu, Scot E. Dowd, Curtis Huttenhower, Matthieu Pichaud, Esra I. Dogan, Jack Satsangi, Randy Longman, Rhonda Yantiss, Lukas A. Mueller, Ellen J. Scherl, R. Balfour Sartor, Kenneth W. Simpson

×

Figure 3

Ileal E. coli use inflammation-associated metabolites and glycerophospholipids for growth, with a differential effect of ethanolamine for AIEC.

Options: View larger image (or click on image) Download as PowerPoint
Ileal E. coli use inflammation-associated metabolites and glycerophospho...
(A) Heatmap of growth (AUC) of ileal AIEC and non-AIEC (n = 10) on ileitis metabolites and constituents of 1H-NMR peaks PC2 and PC3. Data from 1 of 3 independent experiments (2 replicates). Multiple Mann-Whitney U test. (B) Growth (AUC ± SD) of 49 patient derived ileal E. coli (AIEC and non-AIEC) on different combinations of carbon and nitrogen. Mann-Whitney U test. (C) Heatmap of growth (AUC) of 49 ileal E. coli (AIEC red, non-AIEC blue) from phylogroups A, B1, B2, and D on combinations of fucose (F), ethanolamine (EA), glycerol (G), NH4Cl (N), glutamine (GLN), and 1,2-propanediol (PD). (D) Dendogram of the eut operon aligned with growth on EA. Vertical color blocks indicate phylogroup. Superscripts indicate the presence of insertions, deletions or stop codons: a3 bp deletion in eutJ, 12 bp deletion in eutK, 3 bp deletion in eutG; b23 bp insertion in eutQ; c110 bp deletion in eutH; dstop codon in eutD; einsertion sequence in eut operon and eutBCL deletion; f24 bp deletion in eutB; and gstop codon in eutR. Substrates: fucose 20 mM; glycerol 20 mM; 1,2-propanediol 20 mM; NH4Cl 19 mM; ethanolamine 20 mM; Glutamine (GLN) 2.5 mM versus glucose 20 mM in M9 minimal media. (B–D) Average AUC of 3 independent experiments (2 replicates). Data are shown as mean ± SD. **P < 0.01.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts